Heart Failure

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin. 

Patients taking SGLT2 inhibitors were 22% less likely to die from heart-related causes.

The study tracked 2,876 patients hospitalized for acute HF or deteriorating chronic HF.

The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.

Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.

The full analysis was published in Circulation: Heart Failure

The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.

Researchers took a fresh look at data from the EMPEROR-Preserved trial, sharing their findings in Circulation.

“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

The study's authors tracked data from facilities in 11 different countries, examining imaging findings from patients with ICI-related myocarditis. 

The procedure, performed as part of a clinical trial, appears to have been a complete success. 

"Every clinical outcome that we measured favored treatment with valsartan alone," one researcher said. 

Around the web

The measure to extend funding through Feb. 18 does not include any of the changes championed by physicians. 

The specialty needs more female role models like the famed superhero, who became a feminist icon in the 1970s, Carter wrote Friday in JACR

The data can help department leaders better understand “discontinuity” in staff productivity and inform promotion considerations, experts said. 

Trimed Popup
Trimed Popup